Detalhe da pesquisa
1.
Safety, tolerability, pharmacokinetics, and pharmacodynamics of concomitant administration of multiple doses of cagrilintide with semaglutide 2·4 mg for weight management: a randomised, controlled, phase 1b trial.
Lancet
; 397(10286): 1736-1748, 2021 05 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33894838
Mostrar mais
Texto completo
Documentos relacionados
2.
Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial.
Lancet
; 398(10317): 2160-2172, 2021 12 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34798060
3.
Weight loss and risk reduction of obesity-related outcomes in 0.5 million people: evidence from a UK primary care database.
Int J Obes (Lond)
; 45(6): 1249-1258, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33658682
4.
Estimating and reporting treatment effects in clinical trials for weight management: using estimands to interpret effects of intercurrent events and missing data.
Int J Obes (Lond)
; 45(5): 923-933, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33462358
5.
Prevalence of depression in adults with type 2 diabetes in the Basque Country: relationship with glycaemic control and health care costs.
BMC Public Health
; 14: 769, 2014 Jul 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-25073532
6.
Body mass index and risk of obesity-related conditions in a cohort of 2.9 million people: Evidence from a UK primary care database.
Obes Sci Pract
; 7(2): 137-147, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33841883
7.
Body mass index trajectories among people with obesity and association with mortality: Evidence from a large Israeli database.
Obes Sci Pract
; 7(2): 148-158, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33841884
8.
Obesity, cardiovascular risk and healthcare resource utilization in the UK.
Eur J Prev Cardiol
; 28(11): 1235-1241, 2021 09 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-34551077
9.
A comprehensive descriptive assessment of obesity related chronic morbidity and estimated annual cost burden from a population-based electronic health record database.
Isr J Health Policy Res
; 9(1): 32, 2020 06 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-32580788
10.
Efficacy and Safety of Liraglutide 3.0 mg in Individuals With Overweight or Obesity and Type 2 Diabetes Treated With Basal Insulin: The SCALE Insulin Randomized Controlled Trial.
Diabetes Care
; 43(5): 1085-1093, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32139381
11.
A multisectoral approach to the prevention and control of noncommunicable diseases: building the momentum in Belarus
Artigo
em Inglês
| WHOLIS | ID: who-325545
12.
Электронные панели в первичной медико-санитарной помощи: расширение профилактики и ведения неинфекционных заболеваний на уровне первичной медико-санитарной помощи в Хорватии
Копенгаген; Всемирная организация здравоохранения. Европейское региональное бюро; 2018. (WHO/EURO:2018-3319-43078-60293).
em Russo
| WHOLIS | ID: who-345709
13.
14.
Better noncommunicable disease outcomes: challenges and opportunities for health systems. Kazakhstan country assessment
Copenhagen; World Health Organization. Regional Office for Europe; 2018. (WHO/EURO:2018-2990-42748-59631).
em Inglês
| WHOLIS | ID: who-345354
15.
Primary care electronic panels in Croatia: an information solution for more proactive primary health care services: good practice brief
Copenhagen; World Health Organization. Regional Office for Europe; 2017. (WHO/EURO:2017-3319-43078-60292).
em Inglês
| WHOLIS | ID: who-345708
16.
Better noncommunicable disease outcomes: challenges and opportunities for health systems: Croatia country assessment: focus on cardiovascular diseases and diabetes
Copenhagen; World Health Organization. Regional Office for Europe; 2015. (WHO/EURO:2015-8726-48498-72055).
em Inglês
| WHOLIS | ID: who-375126